[Source: The Lancet, full page: (LINK). Summary, edited.]
Neuraminidase inhibitors for influenza-like illness in primary care
Nelson Lee, Michael Ison
Published: December 12, 2019 / DOI: https://doi.org/10.1016/S0140-6736(19)33097-1
Primary care physicians have an important role in managing most of the influenza cases during seasonal epidemics. Symptomatic treatment and antibiotics are commonly prescribed due to undifferentiated manifestations of acute respiratory infections. Neuraminidase inhibitor treatment is recommended in outpatients if they have severe symptoms or are at risk for complications and present within 2 days of illness. 1
However, global use of neuraminidase inhibitor treatment is low. 2
Concerns about the modest benefits and side-effects of neuraminidase inhibitors and inaccessibility to rapid, sensitive influenza diagnostics might have reduced broader use of this treatment.
Keywords: Seasonal Influenza; Antivirals; Oseltamivir.